Novel Therapies for Sleep Apnea—The Implants Have Arrived!

REFERENCES

• Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Quan SF, Troester MW, Vaughn BV. 2017. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications: version 2.4. Darien, IL: American Academy of Sleep Medicine.
   Google Scholar
• Brooks R, Trimble M. 2014. The future of sleep technology: report from an American association of sleep technologists summit meeting. J Clin Sleep Med. 10(5):589–593.
   PubMed Web of Science ®Google Scholar
• Campos-Rodriguez F, Martinez-Alonso M, Sanchez-de-la-Torre M, Barbe F. 2016. Long-term adherence to continous positive airway pressure therapy in non-sleepy sleep apnea patients. Sleep Med. 17:1–6. doi:10.1016/j.sleep.2015.07.038.
   PubMed Web of Science ®Google Scholar
• Charakorn N, Kezirian EJ. 2016. Drug-induced sleep endoscopy. Otolaryngol Clin N Am. 49:1359–1372. doi:10.1016/j.otc.2016.06.002.
   PubMed Web of Science ®Google Scholar
• Chen W, Gillett E, Khoo MCK, Ward SLD, Nayak K. 2017. Real-time multislice mri during continuous positive airway response to pressure change. J Magn Reson Imaging. 46:1400–1408. doi:10.1002/jmri.25675.
   PubMed Web of Science ®Google Scholar
• Coleman M. 2014. Inspire® upper airway stimulation training for physicians and technologists. Training presented at USC Inspire Medical physician and technologist training, Los Angeles, CA.
   Google Scholar
• Costanzo MR, Augostini R, Goldberg LR, Ponikowski P, Stellbrink C, Javaheri S. 2015. Design of the remede system pivotal trial: a prospective, randomized study in the use of respiratory rhythm management to treat central sleep apnea. J Card Fail. 21:892–902. doi:10.1016/j.cardfail.2015.08.344.
   PubMed Web of Science ®Google Scholar
• Costanzo MR, Ponikowski P, Javaheri S, Augostini R, Goldberg L, Holcomb R, Kao A, Khayat RN, Oldenburg O, Stellbrink C, Abraham WT. 2016. Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet. 388:974–982. doi:10.1016/S0140-6736(16)30961-8.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Woehrle H, Wegscheider K, Angermann C, d’Ortho M-P, Erdmann E, Levy P, Simonds AK, Somers VK, Zannad F, Teschler H. 2015. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. NEJM. 373(12):1095–1105. doi:10.1056/NEJMoa1506459.
   PubMed Web of Science ®Google Scholar
• Eldabe S, Buchser E, Duarte RV. 2016. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: A review of the literature. Pain Med. 17:325–336.
   PubMed Web of Science ®Google Scholar
• Gillespie MB, Soose RJ, Woodson BT, Strohl KP, Maurer JT, de Vries N, Steward DL, Baskin JZ, Badr MS, Lin H-S, Padhya TA, Mickelson S, Anderson WM, Vanderveken OM, Strollo PJ. 2017. Upper airway stimulation for obstructive sleep apnea: patient-reported outcomes after 48 months of follow-up. Otolaryngol Head Neck Surg. 156(4):765–771. doi:10.1177/0194599817691491.
   PubMed Web of Science ®Google Scholar
• Hofauer B, Philip P, Markus W, Knopf A, Heiser C. 2017. Effects of upper-airway stimulation on sleep architecture in patients with obstructive sleep apnea. Sleep Breath. 21:901–908. doi:10.1007/s11325-017-1519-0.
   PubMed Web of Science ®Google Scholar
• Inspire Medical Systems, Inc. 2014 May 1. FDA approves inspire® upper airway stimulation (UAS) therapy for obstructive sleep apnea. Inspire Medical Systems, Inc: Press release. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2015 Nov. About obstructive sleep apnea & inspire® upper airway stimulation (UAS) therapy. Inspire Medical Systems, Inc: Press release. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2016 Nov 16. Inspire medical systems completes 1,000th implant, names Marilyn Carlson to the board, and completes series F financing. Inspire Medical Systems, Inc: Press release. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2017a. System Implant Manual. (200-236-101 RevB). Inspire Medical Systems, Inc: Manual. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2017b June 5. Inspire medical systems announces FDA approval of inspire® 3028 neurostimulator for the treatment of obstructive sleep apnea. Inspire Medical Systems, Inc: Press release. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2017c Sep 20. Inspire medical systems’ inspire® therapy for reducing obstructive sleep apnea demonstrates long-term safety and sustained benefit following 5-years of treatment. Inspire Medical Systems, Inc: Press release. Minneapolis, MN.
   Google Scholar
• Inspire Medical Systems, Inc. 2017d. Programmer Manual. (200-081-101 RevD). Inspire Medical Systems, Inc: Manual. Minneapolis, MN.
   Google Scholar
• Pietzsch JB, Liu S, Garner AM, Kezirian EJ, Strollo PJ. 2015. Long-term cost-effectiveness of upper airway stimulation for the treatment of obstructive sleep apnea: A model-based projection based on the STAR trial. Sleep. 38(5):735–743G.
   PubMed Web of Science ®Google Scholar
• Respicardia, Inc. 2017 Oct 10. Respicardia’s remede system receives FDA approval. Respicardia, Inc: Press release. Minnetonka, MN.
   Google Scholar
• Respicardia: remedē®. 2010. System System Implant and Clinician Use Manual. Respicardia, Inc: Press release. Minnetonka, MN.
   Google Scholar
• Srollo PJ, Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, Hanson RD, Padhya TA, Steward DL, Gillespie MB, Woodson BT, Van de Heyning PH, Goetting MG, Vanderveken OM, Feldman N, Knaack L, Strohl KP. 2014. Upper-airway stimulation for obstructive sleep apnea. NEJM. 370(2):139–149. doi:10.1056/NEJMoa1308659.
   PubMed Web of Science ®Google Scholar
• Sullivan CE, Issa FG, Berthon-Jones M, Eves L. 1981. Reversal of obstructive sleep apnoea by continous positive airway pressure applied through the nares. The Lancet. 8225(1):862–865. doi:10.1016/S0140-6736(81)92140-1.
   Google Scholar
• Vanderveken OM, Maurer JT, Hohenhorst W, Hamans E, Lin HS, Vroepog AV, Anders C, de Vries N, Van de Heyning PH. 2013. Evaluation of drug-induced sleep endoscopy as a patient selection tool for implanted upper airway stimulation for obstructive sleep apnea. J Clin Sleep Med. 9(5):433–438.
   PubMed Web of Science ®Google Scholar
• Weaver TE, Grunstein RR. 2008 Feb 15. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc. 5(2):173–178. doi:10.1513/pats.200708-119MG.
   PubMedGoogle Scholar
• Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. 2008. Long-term compliance with continous positive airway pressure in patients with obstructive sleep apnea. Can Respir J. 15(7):365–369. doi:10.1155/2008/534372.
   PubMed Web of Science ®Google Scholar
• Woodson BT, Soose RJ, Gillespie MB, Strohl KP, Maurer JT, de Vries N, Steward DL, Baskin JZ, Badr MS, Lin H-S, Padhya TA, Mickelson S, Anderson WM, Vanderveken OM, Strollo PJ. 2016. Three-year outcomes of cranial nerve stimulation for obstructive sleep apnea: the star trial. Otolaryngol Head Neck Surg. 154(1):181–188. doi:10.1177/0194599815616618.
   PubMed Web of Science ®Google Scholar
• Woodson BT, Strohl KP, Soose RJ, Gillespie MB, Maurer JT, de Vries N, Padhya TA, Badr MS, Lin HS, Vanderveken OM, Mickelson S, Strollo PJ Jr. 2018. Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Head Neck Surg. 154(1):181–188.
   PubMed Web of Science ®Google Scholar